Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
EditorialEditorial

The Infiltrated Radiopharmaceutical Injection: Risk Considerations

Bernard Hoop
Journal of Nuclear Medicine May 1991, 32 (5) 890-891;
Bernard Hoop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 32 no. 5 890-891
PubMed 
1902509

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT © 1991 by The Society of Nuclear Medicine, Inc.

Author Information

Cited By...

  • 9 Citations
  • Google Scholar

Article usage

Article usage: January 2007 to February 2021

AbstractFullPdf
Jan 2007003
Feb 2007003
Mar 2007002
Apr 2007004
May 2007003
Jul 2007001
Aug 2007004
Sep 2007007
Oct 2007004
Nov 2007003
Dec 2007004
Jan 2008006
Feb 2008009
Mar 20080010
Apr 2008007
May 2008005
Jun 2008005
Jul 2008005
Aug 2008003
Sep 2008004
Oct 2008008
Nov 2008004
Dec 2008004
Jan 2009004
Feb 2009002
Mar 2009001
Apr 2009003
May 2009007
Jun 2009004
Aug 2009008
Sep 2009001
Oct 2009009
Nov 20090011
Dec 20090011
Jan 2010006
Feb 2010006
Mar 2010009
Apr 20100017
May 2010004
Jun 2010006
Jul 2010008
Aug 2010007
Sep 20100020
Oct 20100014
Nov 20100023
Dec 2010007
Jan 20110016
Feb 20110011
Mar 2011007
Apr 20110016
May 2011009
Jun 2011001
Jul 2011009
Aug 20110012
Sep 2011008
Oct 20110011
Nov 20110017
Dec 2011008
Jan 20120020
Feb 2012009
Mar 20120016
Apr 20120028
May 20120035
Jun 20120013
Jul 2012009
Aug 20120012
Sep 2012003
Oct 20120021
Nov 20120029
Dec 2012005
Jan 20130014
Feb 20130011
Mar 20130012
Apr 20130018
May 20130019
Jun 20130012
Jul 2013007
Aug 2013009
Sep 20130011
Oct 2013005
Nov 20130014
Dec 2013007
Jan 20140012
Feb 20140017
Mar 2014004
Apr 20140013
May 2014009
Jun 2014004
Jul 2014001
Aug 2014004
Sep 2014009
Oct 2014006
Nov 2014002
Dec 2014008
Jan 20150015
Feb 2015003
Mar 20150013
Apr 201506821
May 20150032
Jun 20150018
Jul 20150014
Aug 2015008
Sep 2015006
Oct 2015009
Nov 2015005
Dec 2015005
Jan 2016003
Feb 20160024
Mar 20160017
Apr 20160021
May 2016007
Jun 2016006
Jul 20160014
Aug 20160017
Sep 20160032
Oct 20160011
Nov 20160017
Dec 20160010
Jan 20170013
Feb 2017007
Mar 20170014
Apr 2017005
May 20170019
Jun 20170018
Jul 20170012
Aug 2017008
Sep 20170012
Oct 20170021
Nov 20170013
Dec 2017009
Jan 20180018
Feb 20180017
Mar 20180013
Apr 20180013
May 20180018
Jun 2018006
Aug 2018001
Sep 2018008
Oct 20180012
Nov 20180015
Dec 20180011
Jan 20190041
Feb 20190020
Mar 20190045
Apr 20190016
May 20190015
Jun 20190013
Jul 20190012
Aug 20190010
Sep 20190018
Oct 20190024
Nov 20190011
Dec 20190014
Jan 20200025
Feb 20200020
Mar 20200018
Apr 20200018
May 20200010
Jun 20200025
Jul 2020009
Aug 20200015
Sep 20200028
Oct 20200011
Nov 20200014
Dec 2020009
Jan 20210018
Feb 20210011
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 32, Issue 5
May 1, 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Infiltrated Radiopharmaceutical Injection: Risk Considerations
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Infiltrated Radiopharmaceutical Injection: Risk Considerations
Bernard Hoop
Journal of Nuclear Medicine May 1991, 32 (5) 890-891;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Infiltrated Radiopharmaceutical Injection: Risk Considerations
Bernard Hoop
Journal of Nuclear Medicine May 1991, 32 (5) 890-891;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Portable Database of Adverse Reactions and Drug Interactions with Radiopharmaceuticals
  • Google Scholar

More in this TOC Section

  • Real-World Data as an Evidence Source in Nuclear Medicine
  • The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation
  • Brain Tau Imaging: Food and Drug Administration Approval of 18F-Flortaucipir Injection
Show more Editorial

Similar Articles

SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire